US FDA Plan For Adopting International Software Guideline Draws Industry Concern
Executive Summary
The US agency was hoping to boost regulatory harmonization with the wholesale adoption of an international guideline on standalone medical device software, but medtech companies are worried that the guideline does not link up with US legislation and requirements.
You may also be interested in...
IMDRF Closing Two Working Groups, Says Jobs Are Done
The International Medical Device Regulators Forum has finished work on two key programs.
Hiring Plans Are Central To US FDA's Digital Health Plan
Hiring experts in artificial intelligence, cloud computing, cybersecurity and related fields is a central part of US FDA's recently announced "Digital Health Innovation Action Plan." The goal of the expanded team will be to make better regulatory decisions, issue new guidances and initiate a "pre-certification" pilot program for software.
Industry Praise US FDA Software Pilot Program
Medtech sector representatives say they are optimistic about FDA's plans to accept up to nine companies to participate in a pilot program that could lead to a new pathway for digital health products.